NDT Advance Access published online on January 23, 2006
Nephrology Dialysis Transplantation, doi:10.1093/ndt/gfk062
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Nephrology, General Hospital of Wiener Neustadt, A-2700 Wiener Neustadt, Austria
* To whom correspondence should be addressed.
Received June 12, 2005
Accepted December 21, 2005
Interesting Case
Gadolinium - a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?
Thomas Grobner 1 *
Thomas Grobner, E-mail: dr.thomas.grobner{at}aon.at
This article has no Abstract.
Keywords:
end stage renal disease; gadolinium-DTPA; metabolic acidosis; nephrogenic fibrosing dermopathy.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. Miyazaki and V. S. Lee Nonenhanced MR Angiography Radiology, July 1, 2008; 248(1): 20 - 43. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Schroeder, C. Weingart, B. Coras, I. Hausser, S. Reinhold, M. Mack, V. Seybold, T. Vogt, B. Banas, F. Hofstaedter, et al. Ultrastructural Evidence of Dermal Gadolinium Deposits in a Patient with Nephrogenic Systemic Fibrosis and End-Stage Renal Disease Clin. J. Am. Soc. Nephrol., July 1, 2008; 3(4): 968 - 975. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Ersoy and F. J. Rybicki MR Angiography of the Lower Extremities Am. J. Roentgenol., June 1, 2008; 190(6): 1675 - 1684. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. F. Reilly Risk for Nephrogenic Systemic Fibrosis with Gadoteridol (ProHance) in Patients Who Are on Long-Term Hemodialysis Clin. J. Am. Soc. Nephrol., May 1, 2008; 3(3): 747 - 751. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Perazella How Should Nephrologists Approach Gadolinium-based Contrast Imaging in Patients with Kidney Disease? Clin. J. Am. Soc. Nephrol., May 1, 2008; 3(3): 649 - 651. [Full Text] [PDF]
|
|
|
|
 |
|
 G. Zaharchuk, A.J. Martin, and W.P. Dillon Noninvasive Imaging of Quantitative Cerebral Blood Flow Changes during 100% Oxygen Inhalation Using Arterial Spin-Labeling MR Imaging AJNR Am. J. Neuroradiol., April 1, 2008; 29(4): 663 - 667. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. C. Kane, A. W. Stanson, D. Kalnicka, D. W. Rosenthal, C. U. Lee, S. C. Textor, and V. D. Garovic Comparison between gadolinium and iodine contrast for percutaneous intervention in atherosclerotic renal artery stenosis: clinical outcomes Nephrol. Dial. Transplant., April 1, 2008; 23(4): 1233 - 1240. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. D. Wiginton, B. Kelly, A. Oto, M. Jesse, P. Aristimuno, R. Ernst, and G. Chaljub Gadolinium-Based Contrast Exposure, Nephrogenic Systemic Fibrosis, and Gadolinium Detection in Tissue Am. J. Roentgenol., April 1, 2008; 190(4): 1060 - 1068. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. P. Golding and J. M. Provenzale Nephrogenic Systemic Fibrosis: Possible Association with a Predisposing Infection Am. J. Roentgenol., April 1, 2008; 190(4): 1069 - 1075. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. M. Shabana, R. H. Cohan, J. H. Ellis, H. K. Hussain, I. R. Francis, L. D. Su, S. K. Mukherji, and R. D. Swartz Nephrogenic Systemic Fibrosis: A Report of 29 Cases Am. J. Roentgenol., March 1, 2008; 190(3): 736 - 741. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Kay, H. Bazari, L. L. Avery, and A. F. Koreishi Case 6-2008 -- A 46-Year-Old Woman with Renal Failure and Stiffness of the Joints and Skin N. Engl. J. Med., February 21, 2008; 358(8): 827 - 838. [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. Leyendecker, C. E. Barnes, and R. J. Zagoria MR Urography: Techniques and Clinical Applications RadioGraphics, January 1, 2008; 28(1): 23 - 46. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Stepansky, E. M. Hecht, R. Rivera, L. E. Hirsh, B. Taouli, M. Kaur, and V. S. Lee Dynamic MR Angiography of Upper Extremity Vascular Disease: Pictorial Review RadioGraphics, January 1, 2008; 28(1): e28 - e28. [Abstract] [Full Text]
|
|
|
|
|
|
P. Marckmann, L. Skov, K. Rossen, J. G. Heaf, and H. S. Thomsen Case-control study of gadodiamide-related nephrogenic systemic fibrosis Nephrol. Dial. Transplant., November 1, 2007; 22(11): 3174 - 3178. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Nortier and V. del Marmol Nephrogenic systemic fibrosis the need for a multidisciplinary approach Nephrol. Dial. Transplant., November 1, 2007; 22(11): 3097 - 3101. [Full Text] [PDF]
|
|
|
|
|
|
J. B. Othersen, J. C. Maize Jr., R. F. Woolson, and M. N. Budisavljevic Nephrogenic systemic fibrosis after exposure to gadolinium in patients with renal failure Nephrol. Dial. Transplant., November 1, 2007; 22(11): 3179 - 3185. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.M. Morris and G.M. Miller Increased Signal in the Subarachnoid Space on Fluid-Attenuated Inversion Recovery Imaging Associated with the Clearance Dynamics of Gadolinium Chelate: A Potential Diagnostic Pitfall AJNR Am. J. Neuroradiol., November 1, 2007; 28(10): 1964 - 1967. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Remy-Jardin, M. Pistolesi, L. R. Goodman, W. B. Gefter, A. Gottschalk, J. R. Mayo, and H. D. Sostman Management of Suspected Acute Pulmonary Embolism in the Era of CT Angiography: A Statement from the Fleischner Society Radiology, November 1, 2007; 245(2): 315 - 329. [Full Text] [PDF]
|
|
|
|
 |
|
 C. Thakral and J. L. Abraham Automated scanning electron microscopy and x-ray microanalysis for in situ quantification of Gadolinium deposits in skin J. Electron Microsc. (Tokyo), October 19, 2007; (2007) dfm020v1. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. A. Collidge, P. C. Thomson, P. B. Mark, J. P. Traynor, A. G. Jardine, S. T. W. Morris, K. Simpson, and G. H. Roditi Gadolinium-enhanced MR Imaging and Nephrogenic Systemic Fibrosis: Retrospective Study of a Renal Replacement Therapy Cohort Radiology, October 1, 2007; 245(1): 168 - 175. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Swaminathan and S. V. Shah New Insights into Nephrogenic Systemic Fibrosis J. Am. Soc. Nephrol., October 1, 2007; 18(10): 2636 - 2643. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Saab, A. Abu-Alfa, E. A. Sadowski, and A. Djamali Are Patients with Moderate Renal Failure at Risk for Developing Nephrogenic Systemic Fibrosis? Radiology, September 1, 2007; 244(3): 930 - 932. [Full Text] [PDF]
|
|
|
|
 |
|
 A. S Peak and A. Sheller Risk Factors for Developing Gadolinium-Induced Nephrogenic Systemic Fibrosis Ann. Pharmacother., September 1, 2007; 41(9): 1481 - 1485. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Swaminathan, T. D. Horn, D. Pellowski, S. Abul-Ezz, J. A. Bornhorst, S. Viswamitra, and S. V. Shah Nephrogenic Systemic Fibrosis, Gadolinium, and Iron Mobilization N. Engl. J. Med., August 16, 2007; 357(7): 720 - 722. [Full Text] [PDF]
|
|
|
|
 |
|
 H. Richmond, J. Zwerner, Y. Kim, and D. Fiorentino Nephrogenic Systemic Fibrosis: Relationship to Gadolinium and Response to Photopheresis Arch Dermatol, August 1, 2007; 143(8): 1025 - 1030. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. S. DeLoach and E. R. Mohler III Peripheral Arterial Disease: A Guide for Nephrologists Clin. J. Am. Soc. Nephrol., July 1, 2007; 2(4): 839 - 846. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. C Thomson, T. A Collidge, P. B Mark, and J. P Traynor Gadolinium contrast may be risky in kidney disease BMJ, June 30, 2007; 334(7608): 1335 - 1336. [Full Text] [PDF]
|
|
|
|
|
|
E. Kanal, A. J. Barkovich, C. Bell, J. P. Borgstede, W. G. Bradley Jr., J. W. Froelich, T. Gilk, J. R. Gimbel, J. Gosbee, E. Kuhni-Kaminski, et al. ACR Guidance Document for Safe MR Practices: 2007 Am. J. Roentgenol., June 1, 2007; 188(6): 1447 - 1474. [Full Text] [PDF]
|
|
|
|
|
|
J. H. Maki, G. J. Wilson, W. B. Eubank, D. J. Glickerman, J. A. Millan, and R. M. Hoogeveen Navigator-Gated MR Angiography of the Renal Arteries: A Potential Screening Tool for Renal Artery Stenosis Am. J. Roentgenol., June 1, 2007; 188(6): W540 - W546. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. S. Thomsen and S. K. Morcos Nephrogenic Systemic Fibrosis and Nonionic Linear Chelates Am. J. Roentgenol., June 1, 2007; 188(6): W580 - W580. [Full Text] [PDF]
|
|
|
|
|
|
E. A. Sadowski, L. K. Bennett, M. R. Chan, A. L. Wentland, A. L. Garrett, R. W. Garrett, and A. Djamali Nephrogenic Systemic Fibrosis: Risk Factors and Incidence Estimation Radiology, April 1, 2007; 243(1): 148 - 157. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Perazella Nephrogenic Systemic Fibrosis, Kidney Disease, and Gadolinium: Is There a Link? Clin. J. Am. Soc. Nephrol., March 1, 2007; 2(2): 200 - 202. [Full Text] [PDF]
|
|
|
|
|
|
P. Yerram, G. Saab, P. R. Karuparthi, M. R. Hayden, and R. Khanna Nephrogenic Systemic Fibrosis: A Mysterious Disease in Patients with Renal Failure--Role of Gadolinium-Based Contrast Media in Causation and the Beneficial Effect of Intravenous Sodium Thiosulfate Clin. J. Am. Soc. Nephrol., March 1, 2007; 2(2): 258 - 263. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. H. Kuo, E. Kanal, A. K. Abu-Alfa, and S. E. Cowper Gadolinium-based MR Contrast Agents and Nephrogenic Systemic Fibrosis Radiology, March 1, 2007; 242(3): 647 - 649. [Full Text] [PDF]
|
|
|
|
 |
|
 R. N. Hellman Erythropoietin, Gadolinium, and Nephrogenic Fibrosing Dermopathy Ann Intern Med, February 6, 2007; 146(3): 229 - 230. [Full Text] [PDF]
|
|
|
|
|
|
I. M. Wahba, K. White, M. Meyer, and E. L. Simpson The case for ultraviolet light therapy in nephrogenic fibrosing dermopathy--report of two cases and review of the literature Nephrol. Dial. Transplant., February 1, 2007; 22(2): 631 - 636. [Full Text] [PDF]
|
|
|
|
|
|
D. R. Broome, M. S. Girguis, P. W. Baron, A. C. Cottrell, I. Kjellin, and G. A. Kirk Gadodiamide-Associated Nephrogenic Systemic Fibrosis: Why Radiologists Should Be Concerned Am. J. Roentgenol., February 1, 2007; 188(2): 586 - 592. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S K Morcos Nephrogenic systemic fibrosis following the administration of extracellular gadolinium based contrast agents: is the stability of the contrast agent molecule an important factor in the pathogenesis of this condition? Br. J. Radiol., February 1, 2007; 80(950): 73 - 76. [Full Text] [PDF]
|
|
|
|
|
|
C. Stollberger and J. Finsterer Dermal and extra-dermal manifestations of gadolinium-triggered nephrogenic fibrosing dermopathy. Nephrol. Dial. Transplant., December 1, 2006; 21(12): 3604 - 3604. [Full Text] [PDF]
|
|
|
|
|
|
R. Nowack and P. Wachtler Scleroderma-like syndrome triggered by Gadolinium Nephrol. Dial. Transplant., November 1, 2006; 21(11): 3344 - 3344. [Full Text] [PDF]
|
|
|
|
 |
|
 Has the Cause of Nephrogenic Fibrosing Dermopathy Been Identified? Journal Watch Dermatology, September 8, 2006; 2006(908): 2 - 2. [Full Text]
|
|
|
|
|
|
P. Marckmann, L. Skov, K. Rossen, A. Dupont, M. B. Damholt, J. G. Heaf, and H. S. Thomsen Nephrogenic Systemic Fibrosis: Suspected Causative Role of Gadodiamide Used for Contrast-Enhanced Magnetic Resonance Imaging J. Am. Soc. Nephrol., September 1, 2006; 17(9): 2359 - 2362. [Abstract] [Full Text] [PDF]
|
|